Methods of using substituted tetracycline compounds to modulate RNA

Details for Australian Patent Application No. 2010202324 (hide)

Owner Paratek Pharmaceuticals, Inc

Inventors Levy, Stuart B.; Draper, Michael; Jones, Graham; Nelson, Mark L.

Agent Watermark

Pub. Number AU-A-2010202324

Parent 2003287217

Filing date 4 June 2010

Wipo publication date 1 July 2010

International Classifications

A61K 31/65 (2006.01) - Tetracyclines

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

24 June 2010 Complete Application Filed

1 July 2010 Application Open to Public Inspection

  Published as AU-A-2010202324

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202325-Method of Gaming

2010202323-Method and system for transferring wireless transmit/receive unit-specific information